Ascend Capital’s Zimmer Biomet ZBH Stock Holding History

Ascend Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-259,676	Closed	-$28.1M	–	226
2018 Q2	$28.1M	Buy	+259,676	New	+$28.3M	1.32%	22
2018 Q1	–	Sell	-250,345	Closed	-$29.3M	–	276
2017 Q4	$29.3M	Buy	250,345 +226,013	+929%	+$25.6M	1.1%	27
2017 Q3	$2.77M	Sell	24,332 -87,916	-78%	-$10.1M	0.1%	131
2017 Q2	$14M	Buy	+112,248	New	+$13.3M	0.65%	54
2017 Q1	–	Sell	-211,220	Closed	-$21.2M	–	187
2016 Q4	$21.2M	Buy	+211,220	New	+$22.6M	1.05%	30
2015 Q3	–	Sell	-360,629	Closed	-$38.2M	–	175
2015 Q2	$38.2M	Buy	+360,629	New	+$39.9M	1.26%	23
2014 Q4	–	Sell	-82,739	Closed	-$8.08M	–	209
2014 Q3	$8.08M	Buy	82,739 +72,439	+703%	+$7.12M	0.24%	121
2014 Q2	$1.04M	Buy	+10,300	New	+$1M	0.03%	159

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Ascend Capital's ZBH Position: Q3 2018 in Review

Ascend Capital sold out of Zimmer Biomet (ZBH) in Q3 2018, closing a stake of 259,676 shares — an estimated $28.1M sold.

Ascend Capital first reported a position in ZBH in Q2 2014 and held it in 8 quarters. The position peaked at $38.2M in Q2 2015. 892 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

Ascend Capital reported no remaining Zimmer Biomet position as of Q3 2018 after selling out during the quarter.
Ascend Capital sold 259,676 Zimmer Biomet shares in Q3 2018, an estimated $28.1M.
Ascend Capital first reported a position in Zimmer Biomet in Q2 2014 and held it in 8 quarters.
Ascend Capital's Zimmer Biomet position peaked at $38.2M in Q2 2015.
892 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.